Canaccord Genuity Maintains Buy on Insulet, Raises Price Target to $432

Benzinga · 11/24/2025 14:52
Canaccord Genuity analyst William Plovanic maintains Insulet (NASDAQ:PODD) with a Buy and raises the price target from $428 to $432.